| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |